These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 15093600
1. Influence of process parameters in the ASES process on particle properties of budesonide for pulmonary delivery. Steckel H, Pichert L, Müller BW. Eur J Pharm Biopharm; 2004 May; 57(3):507-12. PubMed ID: 15093600 [Abstract] [Full Text] [Related]
2. Optimisation of powders for pulmonary delivery using supercritical fluid technology. Rehman M, Shekunov BY, York P, Lechuga-Ballesteros D, Miller DP, Tan T, Colthorpe P. Eur J Pharm Sci; 2004 May; 22(1):1-17. PubMed ID: 15113578 [Abstract] [Full Text] [Related]
3. Stability and aerodynamic behaviour of glucocorticoid particles prepared by a supercritical fluids process. Velaga SP, Bergh S, Carlfors J. Eur J Pharm Sci; 2004 Mar; 21(4):501-9. PubMed ID: 14998581 [Abstract] [Full Text] [Related]
4. Evaluation of supercritical fluid engineered budesonide powder for respiratory delivery using nebulisers. Amani A, Chrystyn H, Clark BJ, Abdelrahim ME, York P. J Pharm Pharmacol; 2009 Dec; 61(12):1625-30. PubMed ID: 19958584 [Abstract] [Full Text] [Related]
12. Ampicillin micronization by supercritical assisted atomization. Reverchon E, Della Porta G, Spada A. J Pharm Pharmacol; 2003 Nov 12; 55(11):1465-71. PubMed ID: 14713356 [Abstract] [Full Text] [Related]
13. Delivery of nebulized budesonide is affected by nebulizer type and breathing pattern. O'Callaghan C, White J, Jackson J, Barry PW, Kantar A. J Pharm Pharmacol; 2005 Jun 12; 57(6):787-90. PubMed ID: 15969935 [Abstract] [Full Text] [Related]
14. Micronization of anti-inflammatory drugs for pulmonary delivery by a controlled crystallization process. Rasenack N, Steckel H, Müller BW. J Pharm Sci; 2003 Jan 12; 92(1):35-44. PubMed ID: 12486680 [Abstract] [Full Text] [Related]
15. Residual solvents in biodegradable microparticles. Influence of process parameters on the residual solvent in microparticles produced by the aerosol solvent extraction system (ASES) process. Ruchatz F, Kleinebudde P, Muller BW. J Pharm Sci; 1997 Jan 12; 86(1):101-5. PubMed ID: 9002467 [Abstract] [Full Text] [Related]
16. Chitosan coated Ca-alginate microparticles loaded with budesonide for delivery to the inflamed colonic mucosa. Simonoska Crcarevska M, Glavas Dodov M, Goracinova K. Eur J Pharm Biopharm; 2008 Mar 12; 68(3):565-78. PubMed ID: 17651952 [Abstract] [Full Text] [Related]
17. Experimental study of the GAS process for producing microparticles of beclomethasone-17,21-dipropionate suitable for pulmonary delivery. Bakhbakhi Y, Charpentier PA, Rohani S. Int J Pharm; 2006 Feb 17; 309(1-2):71-80. PubMed ID: 16412594 [Abstract] [Full Text] [Related]